Evidence map›Paper›PMID 31171749›Full record

ArticleIET nanobiotechnology2019

Synergistic evaluation of AgO

Shamaila Sajjad, Bushra Uzair, Anum Shaukat, Madiha Jamshed, Sajjad Ahmed Khan Leghari, Muhammad Ismail, Qaiser Mansoor

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IET nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. AgPharmaceuticals (Basel, Switzerland) · 2022
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Shamaila SajjadInternational Islamic University, Islamabad, Pakistan. shalisajjad@yahoo.com.
Bushra UzairInternational Islamic University, Islamabad, Pakistan.
Anum ShaukatInternational Islamic University, Islamabad, Pakistan.
Madiha JamshedInternational Islamic University, Islamabad, Pakistan.
Sajjad Ahmed Khan LeghariPakistan Institute of Engineering and Applied Sciences, Islamabad, Pakistan.
Muhammad IsmailInstitute of Biomedical and Genetic Engineering, Islamabad, Pakistan.
Qaiser MansoorInstitute of Biomedical and Genetic Engineering, Islamabad, Pakistan.
International Islamic University, Islamabad · PKInstitute of Biomedical and Genetic Engineering · PKPakistan Institute of Engineering and Applied Sciences · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The silver oxide nanoparticles (AgO

Indexed as

Anti-Bacterial AgentsCeftriaxoneDrug SynergismEscherichia coliMetal NanoparticlesMicrobial Sensitivity TestsOxidesSilver CompoundsAnti-Bacterial AgentsCeftriaxonedisilver oxideOxidesSilver Compounds

Identifiers

PMID31171749
PMCPMC8676072
OpenAlexW2911673171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.